Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Current Strategies in Managing Obesity STRIVE Obesity Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased reduction of inflammation when Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link